Ad
related to: big pharma'scatalent.com has been visited by 10K+ users in the past month
Search results
Big Pharma’s focus on profit is behind medicine shortages, superbug threat
Al Jazeera· 7 days agoMedical authorities around the world are pondering this question as they struggle with shortages of...
Trending tickers: Berkshire Hathaway, Nvidia, Novavax and Adani Enterprises
Yahoo Finance UK· 1 hour agoThe intersection of AI and accelerated computing is set to redefine the future.” The company...
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth
Investing.com· 1 hour agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
Pharma’s $1 Trillion ‘Firepower’ Hangs Over Biotech Stocks in Limbo
Bloomberg· 22 hours agoA flurry of deals at the start of the year sparked optimism for a biotech stock resurgence but a...
Opinion | The Moral Limits of Bankruptcy Law
New York Times· 1 hour agoMs. Jacoby is the author of the forthcoming book “Unjust Debts: How Our Bankruptcy System Makes America More Unequal.” When Purdue Pharma filed for...
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
InvestorPlace· 15 hours agoMany investors expected today’s move in GlaxoSmithKline (NYSE:GSK), with shares of GSK stock...
There's a way to see what Big Pharma is paying your doctor
Quartz· 4 days agoWhen doctors take money or gifts from pharmaceutical companies those are required by law to be...
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
Motley Fool via Yahoo Finance· 21 hours agoWhereas Zepbound and Wegovy both needed a full year of treatment to help patients shed as much...
Pharma awaits Fed relief with $1T in firepower to spend on biotech innovation: report
FierceBiotech· 22 hours ago"The combination of record-level dealmaking capacity seen throughout 2023, firepower of Big Pharma...
Why Trump’s Second Victory Would Be Worse
The Nation· 1 hour agoHow far might Donald Trump go, if given a second chance? What’s different this time, as this special issue details, is that there is now an organized...
